This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Korea University Research and Business Foundation, Cheiljedang Corp.. Active years: 2000-2025.
Company Filing History:
Years Active: 2000-2025
Title: Innovations of Dong Tak Lee
Introduction
Dong Tak Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biosensors and therapeutic agents for neurodegenerative diseases. With a total of 3 patents, his work showcases innovative solutions to pressing health challenges.
Latest Patents
One of his latest patents is a colorimetric sensor kit designed for screening therapeutic agents for neurodegenerative diseases, including a method that utilizes amyloid shelled-gold nanoparticles. This invention allows for easy detection of amyloid degradation by drugs, providing a valuable tool for researchers in the field. Another notable patent is a biosensor for measuring glucose, which incorporates a cytoplasmic membrane filter. This biosensor demonstrates high sensitivity and specificity in glucose detection, even in the presence of signal-interfering substances. Its design allows for various applications, including disposable blood sugar test strips and implantable glucose measuring devices.
Career Highlights
Throughout his career, Dong Tak Lee has worked with esteemed organizations such as Korea University Research and Business Foundation and Cheiljedang Corporation. His experience in these institutions has contributed to his innovative research and development efforts.
Collaborations
He has collaborated with notable colleagues, including Dae Sung Yoon and In Su Kim, further enhancing the impact of his work in the scientific community.
Conclusion
Dong Tak Lee's contributions to the fields of biosensors and therapeutic agents highlight his innovative spirit and dedication to improving health outcomes. His patents reflect a commitment to advancing technology in the medical field, making him a noteworthy inventor in today's landscape.